Jump to content

2022 Cure One, Cure Many Award: A research award for early diagnosis of Lewy body dementia (LBD)

Cashen Almstead

Recommended Posts

Cashen Almstead

The American Brain Foundation is offering over $5.5M in research funds through our 2022 grant programs, and I’m hoping that SfN might help us spread the word about these opportunities to eligible researchers and clinicians. All applications open on July 1, 2021.


The 2022 Cure One, Cure Many Award: A research award for early diagnosis of Lewy body dementia (LBD) is a $3M award seeking to accelerate progress in the diagnosis of LBD. Applications should aim for discovery, validation, and acceleration of LBD-related biomarkers. Projects should specifically have the potential to identify one or more biomarkers that will support or confirm that Lewy body disease is the underlying cause of dementia at any stage. Proposals may address disorders across the LBD spectrum. Pre-proposal applications are due by July 30, 2021 at 5pm CT. The award RFA and application information is available at aan.com/cocm.


We are also offering 18 early career scholarships. Applications are due no later than October 1, 2021; RFAs and application information is available at https://www.aan.com/education-and-research/research/aan-research-program/. Funding is available in the following areas:


  • ALS
  • Alzheimer’s disease and related dementias
  • Cognitive aging and age-related memory loss
  • Epilepsy
  • Frontotemporal degeneration
  • Lewy body diseases
  • Migraine
  • Multiple sclerosis
  • Muscular dystrophy
  • Myasthenia gravis
  • Neuromuscular disease
  • Parkinson’s disease
  • Stroke
  • Tourette syndrome


We are also offering two funding opportunities in neuro health disparities research: an early career Clinical Research Training Scholarship in Neurodisparities, and seed grant funding to promote diversity, equity, and inclusion in autism research.

Link to comment
Share on other sites

  • Create New...